Background image

Artis Cell Therapy Platforms

Artis BioSolutions supports autologous and allogeneic cell therapy programs through integrated process development, analytical development, and cGMP manufacturing under one roof, enabling continuity from early development through clinical production.

Cell Therapy

Cell therapies are uniquely sensitive to process design, material variability, and manufacturing execution. Small changes in activation, expansion, or formulation can significantly impact product performance and regulatory outcomes.

How Artis Executes Cell Therapy Programs

Our translational model connects development and GMP execution from the start. Process and analytical teams work alongside manufacturing and quality groups, reducing tech transfer risk and preserving process knowledge across program stages.